Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William H H Reece

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Randomized phase II studies and their ethicsRaymond P Abratt, William H H Reece, Nathan H Enas, et al.
European Journal of Immunology|April 19, 2006
Dimorphic Plasmodium falciparum merozoite surface protein-1 epitopes turn off memory T cells and interfere with T cell primingEdwin A M Lee, Katie L Flanagan, Gabriela Minigo, et al.
European Journal of Cancer (Oxford, England : 1990)|July 19, 2006
Gemcitabine and split-dose paclitaxel or docetaxel in metastatic breast cancer: a randomised phase II studyKei Siong Khoo, Syed Hasan Manzoor Zaidi, Vichien Srimuninnimit, et al.
Lung Cancer (Amsterdam, Netherlands)|March 10, 2007
Patient attitudes towards chemotherapy as assessed by patient versus physician: a prospective observational study in advanced non-small cell lung cancerDa-Tong Chu, Sang-We Kim, Han-Pin Kuo, et al.
Plos One|March 7, 2020
The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT]Stephen John Clarke, Matthew Burge, Kynan Feeney, et al.
The Journal of Infectious Diseases|October 11, 2003
Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adultsVasee S Moorthy, Margaret Pinder, William H H Reece, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcomeNigel Spry, Jennifer Harvey, Craig Macleod, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Phase II trial of gemcitabine-carboplatin-paclitaxel as neoadjuvant chemotherapy for operable non-small cell lung cancerRaymond P Abratt, Jung Sin Lee, Ji Youn Han, et al.
Nature Medicine|March 23, 2004
A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and diseaseWilliam H H Reece, Margaret Pinder, Philip K Gothard, et al.
Infection and Immunity|February 21, 2002
Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malariaEdwin A M Lee, Dupeh R Palmer, Katie L Flanagan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Randomized phase II studies and their ethicsRaymond P Abratt, William H H Reece, Nathan H Enas, et al.
European Journal of Immunology|April 19, 2006
Dimorphic Plasmodium falciparum merozoite surface protein-1 epitopes turn off memory T cells and interfere with T cell primingEdwin A M Lee, Katie L Flanagan, Gabriela Minigo, et al.
European Journal of Cancer (Oxford, England : 1990)|July 19, 2006
Gemcitabine and split-dose paclitaxel or docetaxel in metastatic breast cancer: a randomised phase II studyKei Siong Khoo, Syed Hasan Manzoor Zaidi, Vichien Srimuninnimit, et al.
Lung Cancer (Amsterdam, Netherlands)|March 10, 2007
Patient attitudes towards chemotherapy as assessed by patient versus physician: a prospective observational study in advanced non-small cell lung cancerDa-Tong Chu, Sang-We Kim, Han-Pin Kuo, et al.
Plos One|March 7, 2020
The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT]Stephen John Clarke, Matthew Burge, Kynan Feeney, et al.
The Journal of Infectious Diseases|October 11, 2003
Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adultsVasee S Moorthy, Margaret Pinder, William H H Reece, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcomeNigel Spry, Jennifer Harvey, Craig Macleod, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Phase II trial of gemcitabine-carboplatin-paclitaxel as neoadjuvant chemotherapy for operable non-small cell lung cancerRaymond P Abratt, Jung Sin Lee, Ji Youn Han, et al.
Nature Medicine|March 23, 2004
A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and diseaseWilliam H H Reece, Margaret Pinder, Philip K Gothard, et al.
Infection and Immunity|February 21, 2002
Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malariaEdwin A M Lee, Dupeh R Palmer, Katie L Flanagan, et al.
Pageof 2